The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
9 pts

Opinion on  Dendreon Corp (DNDN)     Sector: Healthcare  >  Industry: Biotechnology & Drugs
UpDown Virtual Investing: Earn Real Money with Zero Risk

Dec 28, 2008 09:24 PM GMT
Mikerun
Return Risk
+1.04% LOW
Principal

UpDown Virtual Investing: Earn Real Money with Zero Risk



Start earning real money with zero risk while improving your trading skills and strategies at the UpDown Virtual Investing website -- just click on the image above or any of the text links to the site in this article to sign up today. My stats and profile are featured in the accompanying table and on my blog site below the last posted entry. I started trading at the UpDown on 11/23/08 with a gain of about 29% through today -- my profile name on the site is 'ETFinnovators' with a portfolio of long positions and links to recent articles that includes the following stocks since the site does not currently allow users to view each others portfolios.

Apple (AAPL)

AspenBio Pharma (APPY)

CME Group (CME)

China Medical (CMED)

Dendreon (DNDN) – The ultimate biotech binary trade for 2009 with Provenge clinical results expected in mid-2009 and the stock set to either soar into the twenties and beyond with positive results or sink rapidly as I wrote last year for Genitope and Favrille.

Research In Motion (RIMM)

UpDown is the ultimate risk/reward trade since it is free and easy to register and users can earn real money at the site in two ways. The first is by beating the market (S&P 500 Index) on a monthly basis and the second is by referring investors. However, the referral system is designed to encourage legitimate referrals by basing the payment on how much the referred person earns on the site. So, if you refer someone who earns $100, you will receive 10% or $10 as a referral bonus.

The UpDown is also a social networking site for investors, allowing users to form groups, post stock ideas, and collaborate with other investors. The UpDown allows users to trade frequently and closely resembles real-world trading conditions by placing restrictions on maximum positions based on average trading volume and no position may exceed 20% of a user's portfolio value.


DNDN:  This call was made on 12/28/08 @ $4.62
Rating:   Positive   $4.62 (12/28/08)
Closed:   01/10/2009 @ $4.47 (-3.25% in 12 days)


Comments (1)

Add Comment

Arrow_up
Arrow_down
lewislee   N/A     1 point   commented 207 days ago reply

Hi,

One thing that a lot of people have missed in this recent economic down turn is the fact that in-game money for all of the massive multilayer online role playing games has not been effected. I guess it just shows how strong and stable the computer game industry really is.

Virtual Currency


Your Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 21.10 +35.25% 368
2 18.14 +70.90% 206
3 17.66 +25.78% 53
4 13.47 +14.32% 60
5 12.13 +69.23% 34


POPULAR STOCKS
Symbol Company Name Sentiment

TODAY'S HEADLINES

TODAY'S TOP PICKS

 
Dendreon Corp (DNDN)
   SocialPicks Sentiment:   

   This Quarter's Sentiment:
All:
76.0%
Top:
75.0%




Latest Picks by Mike Havrilla
Symbol SP Sentiment Rating Return Since
EXAS Positive -0.76% 11/07/09
NFES N/A Positive n/a 11/07/09
IMUC N/A Positive n/a 11/07/09
ESALY N/A Negative n/a 11/04/09
PFE Negative -0.53% 11/04/09

View All >
   
Mike Havrilla previously rated DNDN
Positive +4.95% New Global Equity Index to Track Immunotherapy, Vaccine Stocks
11/04/2009
9
Positive -0.86% New Stock Indexes to Track Trends in Healthcare Sector
10/28/2009
9
Positive -3.58% Quantum Immunologics: Developing Universal Therapeutic Cancer Vaccine
10/25/2009
9
Positive +4.25% ImmunoCellular (OTC: IMUC.OB): Top Gainer in Cancer Immunotherapy Index
09/16/2009
9
Positive -0.38% Quantum Immunologics: Rodman Conference Recap
09/15/2009
9
Positive +12.11% Mentor Capital (MNTR.pk): A Risk-Mitigated Call Option on QI’s Cancer Immunotherapy
08/29/2009
9
Positive +0.30% Mentor Capital (MNTR.PK) Top Gainer in Cancer Immunotherapy Index
08/28/2009
9
Positive -1.70% Mentor Capital (MNTR.PK): A Stealth Cancer Immunotherapy Play
08/26/2009
9
Positive -1.59% New Indexes to Track Healthcare Trends and More
08/04/2009
9
Positive +14.05% Access Pharma: A Cancer Biotech Call Option Trade
05/27/2009
9
Positive -20.61% Bullish on DNDN ...
04/14/2009
0
Negative +0.00% Updated FDA, Clinical Trial Calendars: CTIC, DNDN, MRX, JNJ, MEDX
04/14/2009
9
Negative -225.72% BioMed Stock Movers: DNDN, EXAS, KG
04/08/2009
9
Negative +3.10% Bearish on DNDN ...
04/07/2009
-1
Positive -0.73% FDA Calendar Updates: SNTS, CEPH, AZN, DNDN, GILD, NVO
04/06/2009
9
Positive +89.63% Calendar of 163 FDA Decisions and Clinical Trials
01/21/2009
9
Positive +2.90% A New Global Healthcare Composite Index
11/23/2008
9
Positive +0.00% A New Index of Emerging Biotech & Pharma Companies
11/22/2008
9





IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch